Dec 6
|
Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting
|
Nov 30
|
Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD
|
Nov 29
|
Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development
|
Nov 17
|
After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO)
|
Nov 15
|
LeddarTech Appoints Chris Stewart as Chief Financial Officer
|
Nov 14
|
Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting
|
Aug 11
|
Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting
|
Aug 10
|
Q2 2023 Bionano Genomics Inc Earnings Call
|
Aug 10
|
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript
|
Aug 10
|
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 9
|
Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress
|
Apr 26
|
Bionano Announces Three Publications Demonstrating OGM’s Utility for Hematological Malignancy Research
|
Apr 24
|
Why Shares of Bionano Genomics Are Up Monday
|
Apr 24
|
UPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates
|
Apr 24
|
Bionano Announces Preliminary Q1 2023 Results and Business Updates
|